EarthFirst Technologies signs Canadian agreement
- Publisher
- Elsevier Science
- Year
- 2004
- Weight
- 36 KB
- Volume
- 2004
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
โฆ Synopsis
Quest's ligand technology is being used by Pfizer for the process development and manufacture of new therapeutic compounds. The relationship covers a range of Chiral Quest's catalysts and ligands. This achievement further supports and develops Chiral Quest's goal of becoming a leading, high value technology provider of products and services to the chiral therapeutics industry.
๐ SIMILAR VOLUMES
Brazil using sugarcane-derived ethanol as feedstock.
## Dividends โข Donaldson Co's board of directors has increased its quarterly common stock cash dividend by 10%, marking the company's 22nd consecutive year of dividend increases. The board declared a regular cash dividend of US$0.11 per share, payable on 14 March 2008 to shareholders of record on
dioxide emissions by 15%. Hydrogen fuel cells are also a potential growing market. Companies operating in this market include PolyFuel. QuantumSphere is developing fuel cell catalysts which use alternative metals such as nickel instead of the more commonly used platinum. Catalytic Solutions and Nano